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The mixed leukocyte culture (MLC) t test has been used as a measure of histocom- 
patibility and as a  model of  the recognition phase of the homograft reaction. Studies 
in man (I), mouse (2), and rat  (3)  have suggested that activation or stimulation in 
MLC is dependent on differences at the major histocompatibility complex (MHC)  al- 
though exceptions to this rule have been found (4). In the mouse the MHC includes 
two serologically defined (SD) loci, H-2K and H-2D, immune response (Ir) loci (5, 6), 
loci governing susceptibility or resistance to tumor viruses (7), and the Ss-Slp loci (8). 
It was naturally assumed that since MLC activation was dependent on MHC  dif- 
ferences, SD antigen differences were responsible for stimulation. Unusual and aber- 
rant cases in human studies (9-12) suggested, however, that in addition to the SD loci, 
there may be MHC  differences which  are difficult to  detect serologically using the 
usual methods of immunization and testing, but which can cause a  lymphocyte pro- 
liferative response. We will refer to such differences as lymphocyte-defined (LD)  dif- 
ferences (13). 
We will present data in this paper which we have  obtained in mouse  MLC 
studies. We have for the most part made use of congenic strains of animals car- 
rying recombinant  MHC  chromosomes  (strains  that  are genetically identical 
except for the genes of the MHC). This allows us to test two animals differing 
for only some segment  of  the  MHC.  In a  few  cases we have  studied  animals 
differing  for  the  MHC  and  for  loci  segregating  independently  of  the  MHC; 
these will be discussed in detail. Our results indicate that  the  strongest  MLC 
activation is associated with  Ir  region differences; H-2K  or H-2D  differences 
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without Ir region differences result in relatively weak or no MLC  stimulation. 
Further,  in  some  cases  we  have  found  mouse  strain  combinations  that  have 
only LD differences (with SD loci identity) whose cells stimulate in MLC.  Brief 
reports dealing with some of these data have been published elsewhere (13,  14). 
Materials  and Methods 
Mice.--For practical purposes it is useful to divide the MHC into four regions: H-2K, IF, 
Ss-Slp, and H-2D (as shown in Fig. 1). The strains used are listed in Table I. With the excep- 
tion of B 10.A (1R) and B 10.A (3R) mice which were kindly sent to us by Dr. Jack H. Stimpfling, 
McLaughlin Research Institute, Great Falls, Mont., all mice were from our own colonies at the 
.....  H-2K  .....  Ir  .....  Ss-Slp  .....  H-2D ..... 
FIG.  l. A map of the mouse MHC showing the two SD locl, H-2K and H-2D, with the Ir 
and Ss-Slp loci in between. The map is discussed in the text. 
University of Michigan and University of Wisconsin. All strains, except AQR, C3H, and HTG, 
were  congenic with strain  C57BL/10Sn  (=B10).  They  were  derived by  intercrossing two 
strains, one of which was B10, followed by repeated backcrossing to B10 with  concomitant 
selection for the H-2 chromosome of the second strain. The eleven cogenic lines used in  the 
present  study underwent  l l  or  12  backcrossings to B10 and  several generations of inter- 
crossing thereafter. Theoretically, after  ll  generations of  backcrossing,  the genome of  the 
congenic lines should be almost identical with the genome of the B10 strain except for the 
H-2 difference. In practice, one can expect that the lines still differ from BI0 not only in the 
H-2  complex but also in whatever differences there might have been between BI0 and the 
second strain in the neighboring segments on both sides of H-2. 
Four  of  the  strains used carried  H-2  chromosomes of independent origin  (H-2 b,  H-2 a, 
H-2 k, and H-2q), the rest of the strains carried recombinant H-2 chromosomes. The chromo- 
somes of independent origin are those for which there is no evidence for exchange of genetic 
material with other chromosomes in their recent history. They differ from one another in their 
SD locl, in at least a portion of the Ir region, and, in some cases, also in the Ss region. Whether 
they also share some portions of the MHC is at present not known. For the purpose of the 
present study the independent MHC chromosomes will be considered as completely different 
from one another in all the regions. The difference is expressed in Table I by assignment of the 
H-2 chromosome symbols to the individual regions (e.g. all four regions of chromosome H-2 b 
are designated with a  capital letter "B," all four regions of chromosome H-2 a with a  capital 
letter "D," etc.). 
The recombinant H-2  chromosomes were derived by intra-H-2 exchange of genetic ma- 
terial  (crossing-over) between two chromosomes of an H-2  heterozygote. The origin of the 
individual recombinant chromosomes was described elsewhere (15). Since, at the present time, 
we know only a  small fraction of the chromosome, the breakage point in the individual H-2 
crossovers can be mapped with only a very limited degree of accuracy. Considering the great 
number of genes constituting the MHC,  it is very unlikely that in any two of the approxi- 
mately 35 known MHC recombinants the break occurred exactly in the same position. Those 
MHC  recombinants which at  the  present  time seem  to  be identical  [e.g.  B10.A(1R)  and 
]~10.A(2R)]  will be most like|y found different after new markers are discovered in the region 
of the break, as has already happened in at least one case [namely B 10.A(2R) and B10.A(4R), 
see below]. 
The different recombinant MHC chromosomes share portions of the H-2 complex with the 
chromosomes from which they were derived, and differ in others. Using a particular eombina- 1432  COMPONENTS OF  THE  MAJOR HISTOCOMPATIBILITY COMPLEX 
TABLE  I 
Strains  Used in Mouse MHC Studies 
Strain  H-2  K  It-1  Ss2Slp  D 
C57BL/10  b  B  B  B  B 
B10.Br  k  K  K  K  K 
B10.D2  d  D  D  D  D 
1310.A  a  K  K  D  D 
B10.A(1R)  h-Sg  K  K  D  B 
B10.A(2R)  h-2Sg  K  K  D  B 
B 10.A(3R)  i-Sg  13  B  D  D 
B 10.A(4R)  h-3Sg  K  K  B  B 
B 10.A(SR)  i-2Sg  B  B  D  D 
B10.G  q  Q  Q  Q  q 
B10.AKM  m  K  K  K  Q 
HTG  g  D  D  D  B 
AQR  y-Klj  Q  K  D  D 
B10.T(6R)  y-Sgi  Q  Q  Q  D 
C3H  k  K  K  K  K 
tion of two MHC chromosomes in an MLC test, a situation can be created in which the re- 
sponding cell will differ from the stimulating cell not by the whole MHC, but by only a small 
portion of it. "[his principle is used in the present study. 
The origin of the congenic lines used here was described by Stimpfling and Reichert (16). A 
few comments should, however, be added about some of the lines. Line B10.G was derived by 
Stimpfling from a noninbred stock obtained from Dr. Margaret C. Green. The stock carried 
two marker genes in linkage group IX, tufted (if) and Brachyury (T). The H-2 chromosome 
derived from this stock was typed by Stimpfling and Reichert as a chromosome which "re- 
sembles but seems not to be identical with H-2~.  '' Our own analysis (Klein, J., unpublished 
data)  of the B10.G line indicates that its H-2 type is serologically indistinguishable from the 
H-2  q type of strains DBA/1, T138,  and Green's tf-T stock. Thus for our purposes, the H-2 
type of line B 10.G will be considered identical with H-2  q. 
Cells  of  lines  BI0.A(2R)  and  B10.A(4R)  are  serologically  indistinguishable from  one 
another. All efforts to date to produce antibodies by cross-immunization of these two lines 
have failed. Skin graft exchanges betueen the two lines are accepted for at  least 40  days 
(although there might he some occasional  rejections beyond this period of time). They also 
respond similarly to synthetic pob3~eptides , such as (T,G)-A--L (17). This response is con- 
trolled by gene(s) in the Ir region. The two lines, however, are not completely identical. First, 
they differ in their response to gamma G2~ allotype (18), a trait which is also controlled by the 
ir region, and second, they differ by the Slp antigen. Thus, although the two recombinants 
were derived from the same two MHC chromosomes (H-2 a and H-2 b) by a recombinational 
event which occurred in the I r region,  the crossover apparently did not occur in exactly the 
same position. 
Strain AQR was derived from a cross (T138)<  B10.A)F~  X  B10 as an H-2 recombinant 
(19). After the first backcross, three additional backcrosses were made to BI0 before the line 
was established by intercrossing. Thus, although the AQR line is not congenic  with B10,  it 
carries a considerable portion of the B10 genome. 
Line B10.T(6R)  was derived by  Stimpfling and  Reichert  (16) as  an H-2  recombinant 
between H-2 a of B10.A and H-2 q of Green's tf-T stock. The line still carries the markers out- 
side the H-2  complex  (tf, T)  and  apparently the whole chromosomal segment of the tf-T 
stock delineated by these two markers (over  15 map units long). The BI0.T(6R) line is sero- 
logically  indistinguishable from AQR, at least with respect to the known H-2 antigens. At- F.  H.  BACH,  M.  B.  WIDMER,  M.  L.  BACH,  AND  J.  KLEIN  1433 
tempts to obtain antibodies by cross-immunization of the two strains have so far been un- 
successful. However, skin grafts transplanted from B10.T(6R) donors onto (B10)< AQR)F1 
recipients are rejected within 3 wk after transplantation (Klein, J., unpublished data). Whether 
the rejection was due  to  residual minor histocompatibility differences [very unlikely since 
B10.T(6R) and B10 are thought to be congenic],  to some difference within the MHC  (the two 
lines differ in both the Ir and Ss regions), or an unknown histocompatibility locus outside of 
H-2 (possibly between T and H-2) is at present not known. 
Strain HTG was derived as an H-2 recombinant from a  cross (BALB/c  X  C57BL)F1  X 
C57BL (20) and was maintained thereafter mostly by sib-sib matings, rI~US it also contains a 
considerable portion of the B10 genome. 
MLC  Technique.  -The MLC  method we have used in these studies will be described in 
detail elsewhere. In brief: MLC tests were done using a  micromethod recently described for 
human cultures (21).  Mouse spleen cells were used as both responding and stimulating cells. 
In most experiments the cells were cultured using 1 X  106 responding cells and I  )< 108 mito- 
mycin  C-treated  stimulating cells/0.2 ml culture well.  In some combinations different cell 
concentrations were  tested.  The cells were  cultured in  tissue culture medium RPMI  1640 
supplemented with pooled frozen human plasma, penicillin, and streptomycin. The human 
plasma, after thawing and heating at 56°C for 30 min, was used at a final concentration of 5% 
(v/v). The cells were cultured for 3 days after which time 2 #Ci of tritiated thymidine (specific 
activity 1.9 C/mM) is added to each culture. The cultures are precipitated approximately 16 
hr later after overnight labeling using an automatic multiple sample harvester (22). 
Stimulation in allogeneic mixtures is expressed and evaluated in two ways. First,  to test 
whether stimulation has occurred in a  given allogeneic mixture, a  t test is performed on the 
log converted counts per minute (cpm) of the allogeneic mixture compared with the log cpm 
in the isogeneic control mixture (the same responding cells with isogeneic or syngeneic mito- 
mycin C-treated "stimulating" cells). The significance of stimulation is then expressed by a P 
value. Second, to compare the response of cells of one strain with a number of different stimu- 
lating cells, for instance differing from the responding ceils by different regions of the MHC, 
results in each combination are expressed as a ratio of cpm in the allogeneic mixture divided 
by cpm in the isogeneic control. Whereas there are probably drawbacks to the use of the ratio 
method, it is one way to pool results from several experiments testing the same combinations. 
RESULTS 
In  the studies presented  in this paper,  we  have  tested  a  total of  173  strain 
combinations  in  one-way  mixed  lymphocyte  culture  involving  15  different 
strains.  Most  experiments were set up by combinatorial protocol; one example 
of such an experiment is given in Table II. 
TABLE  II 
MLC Responses in Selected Mouse Strains 
Stimulator 
Responder  B10  B10.Br  BI0.D2  B10.G 
]310  (3,865  -4-  429)*  26,903  4-  2932  26,858  4-  1873  24,960  4-  5750 
]310.Br  23,124  4-  170  (4,380  4-  715)  16,326  4-  3034  14,672  4-  4668 
B10.D2  14,925  4-  2616  13,227  4-  628  (2,415  ±  467)  14,847  4-  1747 
B10.G  21,619  4-  2185  18,715  4-  2493  25,730  4-  1667  (2,469  4-  474) 
P  <  0.001  in all allogeneic mixtures. 
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In this particular experiment cells of four mouse strains that carry nonrecom- 
binant MHC chromosomes are tested in all possible combinations. The control 
counts per minute plus or minus standard  deviation are given in parentheses; 
cpm in the allogenic mixtures  are compared with the control values using the 
same responding cells.  The P  value given in the table reflects the level of sig- 
nificance  of stimulation  as  discussed  above.  In each  allogenic  one-way MLC 
there  is  highly significant  stimulation  (P  <  0.001)  between  any two of these 
four strains.  Results given in this paper  are either representative  experiments, 
such as the one given in Table II, or data pooled from several experiments in- 
volving that same strain combination. In the latter case, the ratio method will 
be used to express the results. 
MHC Differences for the H-2D Region Only.--Five different strain combina- 
tions, identical for the H-2K, Ir-l, and Ss-Slp regions were tested for their abil- 
ity to stimulate in one-way MLC.  Stimulation in these combinations was uni- 
formly low,  and in some cases not significant.  The results  shown in Table  III 
TABLE  III 
M LC Response with only an II-2D Region Difference 
Stimulator 
Responder 
B10.G  B 10.T (6R)  B 10,AKM 
B10.G  (3,512  ±  983)*  10,434  ±  1300  25,388  ±  3286 
P  <  0.005~  P  <  0.001 
B10.T(6R)  7,348  4-  720  (3,440  4-  1409)  '44,151 4-  1472 
P  <  0.025  P  <  0.001 
B10.AKM  23,627  ±  4298  39,535  ±  3982  (3,727  4-  1068) 
P  <  0.001  P  <  0.001 
* Counts per minute  (cpm) ±  standard deviation. 
:~ Probability  that  cpm in allogeneic mixture  differs from the epm in  isogeneic control 
mixture using the same responding cell. 
are from an experiment in which we noted one of the strongest stimulating com- 
binations  with only an H-2D region different.  B10.AKM cells  are included  as 
"control" cells. The response of B10.G cells to B10.T(6R) mitomycin C-treated 
stimulating  cells was significantly  stronger  than  the  response  in  the  opposite 
direction in all four times of testing. On two occasions the response of B10.T(6R) 
cells to B10.G stimulating ceils was not significant. 
A  total of 10 combinations involving 9 strains differing only for H-2D have 
been  tested.  The  average ratio  of stimulation was only 1.8  (varying from 0.8 
to 5.4). In 11 of 24 ailogenic mixtures the stimulation was insignificant by  t test; 
in only 4 of 24 was the stimulation significant with P  <  0.001. 
One would thus have to conclude that H-2D region differences  are either only 
weakly stimulatory or in some cases perhaps not at all stimulatory (14). It can 
not be ruled out that the failure to obtain stimulation in some cases represents 
an insensitivity of the MLC method being used. Y.  H.  BACH,  M.  B.  WIDMER,  M.  L.  BACIt,  AND  J.  KLEIN  1435 
MHC Differences for the H-2K Region Only.--We have tested one combina- 
tion which differs for only the H-2K region, B10.A versus AQR. This combina- 
tion differs for minor loci segregating independently of the MHC as well as at 
the K  end of the MHC. The results obtained in four separate experiments in- 
volving these two strain combinations, tested in both directions in each experi- 
ment, also suggest that there is little if any stimulation in this combination. 
One example of MLC tests in this combination is given in Table IV. This repre- 
sents the strongest stimulation obtained in any of the experiments. In five of the 
eight cases, P  values obtained were not significant. The average ratio of stimu- 
lation for AQR responding to B10.A was 1.5 (with a range of 0.8-2.2); for B10.A 
responding to AQR,  1.4 (with a range of 0.8-2.0). 
MHC Differences with SD Loci Identity.--One set of three strains, B10.A(1R), 
B10.A(2R),  and B10.A(4R), is of special interest since these strains were de- 
rived from different crossovers involving the same F1 genotype. The genotypes 
of the H-2a/H-2  b heterozygote and three resultant  recombinant chromosomes 
are given in Fig. 2. Since the 1R, 2R, and 4R strains were derived in this manner 
and are on a congenic background, they differ only for the portion of the MHC 
between  the  two  SD  loci  as  indicated.  1R  and  2R  are,  with  respect  to 
the markers available to us, identical, although, the recombinational events may 
TABLE  IV 
MLC Response with SD Loci Identity 
Stimulator 
Responders 
AQR  B10.T(6R)  B10.A 
AQR  3,567  4-  1190"  32,087  4-  1900  7,869  4-4- 439 
P  <  0.001~  0.01  <  P  <  0.025 
B10.T(6R)  44,181  4-  2071  3,440  4-  1409  52,402  4-  4292 
/' <  0.001  P  <  0.001 
BI0.A  8,425  4-  722  25,823  4-  1583  6,856  4-  1416 
0.1  <  P  <  0.2  P  <  0.001 
* Counts per minute (cpm) 4- standard deviation. 
Probability  that  cpm in  allogeneic mixture differs from  the  epm in isogeneic control 
mixture using the same responding cell. 
H-21(k  It-1 k  Ss-Slp d  H-2D  d 
H-2 a/b heterozygote 
FIG. 2. The strains B10.A(1R), B10.A(2R), and B10.A(3R) were all derived from an H-2 
a/b heterozygote. The genotype of the heterozygote as well as the recombinant chromosomes 
are shown in this figure.  1R and 2R were derived by a recombinational event between Ss-Slp 
and H-2D; 4R by a  recombinational event between Ir-I and Ss-Slp.  2R and 4R differ  for an 
Ir locus.  (R. Lieberman. 1972. Fed. Proc.  111:777.) 
H_gK b  Ir-1 b  S.%SlI5 b  H-2D b 
H_2K  k  Ir_l k  Ss-Slp d  H-2D  b  B10.A(1R) chromosome 
H_2K  k  Ir_l k  Ss-SI#  d  H-2D b  B10.A(2R) chromosome 
H_2K  k  Ir-1 k  Ss-Slp b  H-2D  b  B 10.A(4R) chromosome 1436  COMPONENTS  OF  THE  MAJOR  HISTOCOMPATIBILITY  COMPLEX 
have taken place at different positions. Both 1R and 2R cells reproducibly and 
significantly stimulate the cells of the 4R strain, however there is either a very 
weak or no response of 1R or 2R cells to 4R stimulating cells.  Since this uni- 
directional response is an unusual finding we have tested the cells of these strains 
at multiple concentrations of stimulating and responding ceils assayed on sev- 
eral days to maximize response using this MLC method. Whereas we have ob- 
tained an occasional stimulation value where cells of 1R or 2R respond  weakly 
but significantly to stimulating cells of 4R, for the most part MLC tests in this 
direction have failed to stimulate. 
In this particular combination the Slp antigen is present in mice of the  1R 
and 2R genotype but absent from mice of the 4R genotype. Since the Slp antigen 
is present  only in males given the presence of the Slp  ~ gene,  we  have  tested 
whether there is a difference of response of males and females in this particular 
combination to further exclude the Slp antigen as reason for stimulation. Results 
of one such experiment which also illustrates the above discussion are shown in 
Table V. Cells of B10.D2  male and female of comparable age are included in 
the experiment as control cells. There is highly significant stimulation with cells 
of 4R responding to 1R and 2R; there appears to be no significant influence of 
sex on stimulation or response in this combination. These studies would suggest 
that stimulation is not due to the Sip antigen, but to LD loci of the MHC. 
There  are  some examples in  these  experiments of weak  but  significant re- 
sponse of 1R to 4R and 2R to 4R, as well as mixtures in which 1R and 2R cells 
respond significantly to each other; neither response has been observed consist- 
ently. 
The other  strain  combination of great interest  is that of AQR-B10.T(6R). 
This combination differs not only for the MHC genotypes, as shown in Table I, 
but also for minor loci, Our studies indicate however that these minor loci dif- 
ferences either do not lead to MLC activation or are extremely weak in doing 
so. This is based on the finding already discussed above, wherein cells of AQR 
were tested for their response to stimulating cells of B10.A,  which differ from 
AQR at H-2K as well as the same two minor loci by which AQR and B10.T(6R) 
differ (Klein, J., unpublished data). [B 10.A and B10.T(6R) are genetically iden- 
tical except for the MHCI. Since there was repeatedly very little stimulation in 
the AQR-B10.A combination, it must be concluded that, even if the I-I-2K dif- 
ference does not  lead  to  any MLC  activation,  stimulation due  to minor loci 
differences is very weak. 
Stimulation in the mixture of serologically identical AQR-B10.T(6R)  cells is 
strong and highly significant. The results of one experiment are shown in Table 
IV. There is stimulation in both directions in one-way MLC tests and this stim- 
ulation is highly significant in both directions. We must therefore again conclude 
that stimulation is associated with LD differences of the MHC although in this 
particular case we cannot conclude whether MLC stimulation is due to LD dif- 
ferences located between the two SD loci  and/or outside the SD loci. F. H. BACH, M. B. WIDMER~ M. L. BACH, AND ].  KLEIN  1437 
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Various  MHC Differences.--Since  so few strain combinations are  available 
which differ for only one of the four regions of the MHC, we have given further 
examples of our MLC data from experiments in which mice carrying recombi- 
nant MHC chromosomes were tested (Table VI) so that the relative contribu- 
tions of the different MHC regions (taken one, two or three at a time) can be 
compared; the MHC regions by which the stimulating cell differs from the re- 
sponding cell are designated by the MHC chromosome carried by the stimu- 
lating cell.  Each responding cell is shown with all of the  different cells which 
have been used to stimulate it. For a responding cell-stimulating cell combina- 
tion, the number of experiments in which that particular combination was in- 
cluded, the average ratio of stimulation and range of ratios obtained are given. 
It is possible to evaluate the relative contribution of the MHC  regions by 
comparing combinations that differ for different parts of the MHC. The data 
from experiments with  15  different responding cell strains are summarized in 
this fashion in Table VII. As judged by the ratio method, there is strong stim- 
ulation in all combinations as long as the Ir region difference is included. If the 
Ir region is the same in both responding  and  stimulating cells,  the stimulation 
ratio obtained is much lower. 
DISCUSSION 
The mouse MHC map given in Fig. I needs discussion in view of recent find- 
ings regarding the genetics of this region. Calculations based on the frequency 
of crossing-over between H-2K and H-2D (approximately 0.4%) indicate that 
the chromosomal segment occupied by the MHC  could encompass some 500 
genes of 1000 nucleotide pairs each (23). According to the traditional interpre- 
tation of the H~2 system, many of these genes scattered throughout the whole 
chromosomal segment are involved in the control of the different H-2 antigens. 
This interpretation has led recently to a series of internal inconsistencies which 
could be overcome only by presupposition of such unlikely events as double or 
even triple crossing-over within a short chromosomal segment, distorted segre- 
gation, presence of two antigens controlled by two different genes on the same 
molecule, etc. In face of these difficulties it was suggested to abandon the tra- 
ditional  interpretation  and  replace  it  with  a  simple  and  virtually  inconsist- 
encies-free two-gene model of the H-2 system (24). According to the two-gene 
model, most, if not all,  of the serologically detectable  (SD)  H-2  antigens  are 
controlled by one of the two (and in some cases by both) H-2 loci, H-2K and 
//-2/9, which are located at the opposite ends of the MHC. The chromosomal 
segment between the two SD loci can thus encompass a great number of genes. 
The products of these genes, however, do not seem to be serologically detectable 
(at least not so far). The loci of the middle segment of the H-2 complex have 
been shown to be involved in such functions as immune response to synthetic 
polypeptides (17)  and gamma globulin allotypes (25), susceptibility or resist- 
ance to tumor viruses (7), production of serum proteins Ss and Sip (26), and as TABLE  VI 
MLC Response in Various Mouse Strcin Combinations 
Responder  Stimulator 
B1O.Br  C57BL/10 
B10.D2 
B1O.A 
BlO.A(lR) 
B IO.A(2R) 
BIO.A(3R) 
B10.A(4R) 
B 10.A (5R) 
BIO.G 
B1O.AKM 
HTG 
AQR 
C57BL/10 
B 10.Br 
B10.D2 
BlO.A(lR) 
B lO.A(2R) 
BIO.A(3R) 
BlO.A(4R) 
BlO.A(SR) 
B1O.G 
B1O.AKM 
HTG 
AQR 
BlOA(2R)  C57BL/10 
B1O.Br 
B10.D2 
BIO.A 
BIO.A(lR) 
BlO.A(3R) 
B lO.A(4R) 
BlOA(5R) 
B1O.G 
B10.AKM 
HTG 
AQR 
B1O.AKM  C57BLf10 
B1O.Br 
B10.D2 
B1O.A 
B IO.A(lR) 
B lO.A(2R) 
BiO.A(3R) 
BlO.A(4R) 
B1O.G 
HTG 
AQR 
B lO.T(6R) 
Major histocompatibility 
complex 
K  Ir-I  Ss-Slg  D 
Average 
No,  ratio of 
Exp.  stimu- 
lation 
Range 
B  B  B  B 
D  D  D  D 
D  D 
D  B 
D  B 
BBDD 
B  B 
BBDD 
Q  Q  Q  Q 
Q 
DDDB 
Q D  D 
QQQQ 
K  O 
B  B  D 
13 
B  B  D 
QQQQ 
K  Q 
D  D 
Q  D 
BBBB 
K 
D  D  D  D 
D  D 
D  B 
D  B 
BBDD 
B  B 
QQQ 
DDDB 
Q D  D 
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TABLE VII 
Summary of MLC Responses 
MHC regions which are different 
Ratio of stimulation 
Range*  Average 
K, It-l, Ss-Slp, D  1.2-33.6  7.2 
K, lr-1, Ss-Slp  1.4-15.7  6.1 
K, Ir-1, D  3.3-20.5  7.0 
K, Ss-Slp,  D  1.5- 8.6  3.3 
Ir-1, Ss-Slp, D  2.7-15.1  8.3 
K, It-1  3.2-18.3  6.6 
K, Ss-Slp  No experiments 
Ir-1, Ss-Slp  2.7-12.8  5.8 
K,D  3.0-  3.8  3.4 
tr-1, D  No experiments 
Ss-Slp,  D  O. 7- 4.7  2.0 
K  0.8- 2.2  1.4 
Ir-1  No experiments 
D  0.8- 5.4  1.8 
Ss-Slp  0,6- 4.9  2.0 
None  0,6-  1.9  1.2 
* These numbers represent the lowest and highest ratios of stimulation noted. 
demonstrated here, control of MLC response  (13). We have divided the MHC 
into four regions, It-2K,  Ir, Ss,  and H-2D,  as shown in Fig.  1. However this 
does not imply that all the immune response genes have to be limited to the Ir 
region, or genes for serum proteins to Ss region, etc. It is quite possible that Ir 
genes asociated with the H-2D locus rather than H-2K locus will  also be found. 
The evidence for the  two-gene model was discussed  by Klein  and  Shreffler 
(15).  All  the  considerations  in  the  present  paper  are  based  on  the  two-gene 
model. Obviously, the interpretation of the results presented here would change 
considerably if the traditional  and not the two-gene model were true. 
The initial  correlation suggesting that the  MLC  reaction was  activated  by 
differences of the MHC  assumed in large measure  that  activation was due  to 
differences for the SD antigens. The present studies indicate that MHC differ- 
ences which lead to MLC activation are at least in some cases genetically sepa- 
rable  from the  SD  loci.  Further,  an over-all evaluation  of the  data  indicates 
that the  SD differences themselves  are only weakly stimulatory or not stimu- 
latory at all in the MLC. For instance,  some of the H-2D region differences do 
not stimulate.  Other H-ED region differences stimulate weakly. These  findings 
could be explained  either by assuming that the  SD  antigens of H-2D vary in 
their strength as reflected in MLC and that the cases of nonstimulation noted 
by us simply reflect  an insensitivity  of the  MLC  technique,  or that in those 
H-2D differences  which result  in stimulation,  the  recombinational  event pro- 
ducing the H-2D different strains  occurred such that LD  differences were in- 
cluded.  The  single case of an isolated H-2K  region difference which we have F.  H.  BACH,  M.  B.  WIDMER,  M.  L.  BACH,  AND  .].  KLEIN  ]441 
studied includes minor loci incompatibilities as well as the MHC SD difference 
and as such the low level of stimulation is difficult to analyze. Whatever the 
case, it is clear that this H-2K difference is not a  strong one with respect to 
MLC. 
The strongest stimulation is seen when there are differences for the Ir region. 
This is true when all the data is summarized as seen in Table VII, as well as in 
individual experiments involving as many as thirteen strains.  Most revealing 
are those combinations that differ only for the genetic region between the two 
SD loci, such as 1R, 2R, and 4R. The 2R and 4R strains, which differ for the 
immune response locus described by Lieberman, stimulate repeatedly and sig- 
nificantly in one direction, 4R responding to 2R, and much more weakly or not 
at all in the other direction. This demonstrates unequivocably that MLC ac- 
tivation can be caused by genetic differences other than the SD loci and fits in 
well with the over-all pattern of stimulation associated with the Ir region. The 
studies with AQR-B10.T(6R) are also in accord with this finding although here 
there may be genetic differences outside the SD loci as well as between them. It 
is not clear with which of these differences the MLC activation is associated. 
The occasional instances of significant stimulation in the  1R-2R combination 
may indicate that these strains differ for an LD locus. 
Rychlikova et al. (27) claimed that the MLC stimulation is an exclusive prop- 
erty of the H-2K end of the MHC. In view of our results, this claim now has to 
be modified in the following way: First, MLC stimulation is not limited to the 
K  end; D  end differences, at least in some combinations, do stimulate. Second, 
although the K  end differences usually show much stronger stimulation than 
the D  end differences, the stimulation is not primarily due to the H-2K locus 
itself, but to the Ir region. Since the Ir region is closely linked to the H-2K locus, 
a false impression that the tt-2K locus was stronger than the H-2D locus was 
obtained from the results of these authors. 
It is of course of great interest to ask what the LD locus product is.  Since 
the LD locus  (loci) map with the Ir loci it is possible to suggest that  the Ir 
and LD loci are identical. Benacerraf and McDevitt  (5) have suggested that 
the Ir locus product may be a T cell receptor; we would extend this suggestion 
to say that the Ir  (LD) locus product is a T  cell receptor and that this same 
cell surface component can act as a  stimulatory molecule (in the stimulating 
cells)  to which responding lymphocytes can react. Any cell that  has  one or 
more Ir products that a second cell does not have might stimulate that second 
cell in MLC.  It seems quite likely that  there are Ir loci in this region other 
than those currently described; the product of each of these could thus func- 
tion as a  stimulatory molecule. While it appears extremely difficult (and per- 
haps impossible) to obtain cytotoxic or agglutinating antibodies against these 
differences, it may be that another form of antibody, such as a blocking anti- 
body,  is  produced  (28).  Studies  are  currently underway  to  investigate  this 
possibility. 
However, the LD product may be different from the Ir product; several possi- 1442  COMPONENTS  OF  THE MAJOR HISTOCOMPATIBILITY  COMPLEX 
bilities  exist.  The LD  product  might  be  recognized by thymus-derived  (T) 
lymphocytes which  are  involved in  cell-mediated immunity  (graft rejection) 
and probably to a large extent in the MLC reaction, but cannot stimulate those 
bone marrow (B) lymphocytes which produce classical antibody. A close physi- 
cal association in the membrane between the LD  and SD loci products would 
also explain certain correlations found in studies between the SD antigens and 
MLC response as discussed below. As such, the LD locus product may function 
as a "carrier" while the SD product is the "hapten." Alternatively it is known 
that  there are loci in the MHC which affect susceptibility to viral infection; 
perhaps  in  a  case  such  as  the  2R-4R  combination,  the  2R  cells  carry viral 
antigens which are recognized by the 4R ceils. 
Our  studies  in  the  mouse  show  the  following picture  for  the  relationship 
between the LD loci, MLC activation, and graft survival. In one combination, 
AQR-B10.T(6R), skin grafts are rejected in 14-18 days, in all probability due 
to  the  MHC  incompatibility  (see  Materials  and  Methods  section).  These 
findings are similar to the studies of Bailey et al. in which MHC difference(s) 
with SD identity can lead to graft rejection (29)  and reciprocal stimulation in 
MLC3 On the other hand, in the 2R-4R combination, which causes clear MLC 
activation in at least one direction, there is no rapid skin graft rejection, but 
there is a  graft-versus-host  (GvH) reaction as assayed by splenomegaly. Cells 
of B10.A(4R) animals cause a GvH reaction in B10.A(2R) recipients; there is 
no GvH reaction when B10.A(2R) ceils are injected into B10.A(4R) recipients,  a 
Whether this is due to a greater sensitivity of the MLC method compared with 
skin grafting, to the finding of only one-way stimulation which is reproducibly 
demonstrable in the MLC test (which is a very unusual observation in normal 
combinations), to the fact that in some cases it is possible to get MLC activa- 
tion in vitro without having a histocompatibility difference which can lead to 
skin graft rejection, or to differences between skin and lymphoid cells as target 
cells, remains the subject of further investigation. 
While it is impossible to conclude from these studies whether the SD  anti- 
gens can themselves result in MLC activation, it does appear that loci spread 
over a large portion of the MHC region between the two SD loci and perhaps 
outside the  SD  loci can determine products which  are  stimulatory in MLC. 
Again  several interpretations of this phenomenon are possible.  Two are per- 
haps of special interest. First, it may be that there are several evolutionarily 
similar LD  loci in  the  MIIC,  all  with  a  similar  phenotypic product.  These 
products,  quite  likely cell  surface  components,  could  function  as  histocom- 
patibility antigens. Second, it may" be that the LD loci determine molecularly 
and perhaps functionally different surface membrane components which  can 
be recognized as foreign, thereby stimulating in MLC. 
The findings presented in this paper force us to reevaluate the genetic and 
2 Widmer, M. B., F. H. Bach, and D. W. Bailey.  Manuscript in preparation. 
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immunological  complexity  of  the  major  histocompatibility  complex.  The 
possibility that the MLC test can be used to detect the Ir loci products or al- 
ternatively define yet other loci of this region present exciting possibilities for 
further research. 
S~MARY 
The mixed leukocyte culture  (MLC)  test is an in vitro model of the recog- 
nition phase of the homograft response. For the most part, activation in MLC 
is dependent  on differences of the major histocompafibility complex  (MHC). 
Our present studies in the mouse suggest that activation is primarily associated 
with differences of genetic regions of the MHC other than those which  control 
the serologically defined (H-2) antigens. These differences do not lead  to cyto- 
toxic or agglutinating antibody formation despite extensive immunization; we 
have called these differences lymphocyte-defined (LD)  differences. The stron- 
gest  stimulation  in MLC  is  associated with differences  of the Ir region. It is 
possible that the Ir  product  is  the  T  cell  receptor  and  that  it  is  this  same 
molecule which can act as the stimulatory  agent  in  MLC.  Other  possibilities 
are discussed. 
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